The FDA has approved Widaplik (telmisartan, amlodipine and indapamide) for the treatment of hypertension, including as initial treatment, to lower blood pressure.

The approval was supported by data from the randomized, double-blind, placebo-controlled, phase 3 ARANOTE trial.

The European Commission (EC) has approved a label extension for Roche’s Evrysdi (risdiplam) to include a tablet for people living with SMA.

The European Commission approved a tablet formulation of SMA treatment Evrysdi, a form aimed at giving patients more ...

The Food and Drug Administration approved the new vaccine for use in all adults 65 and older, and for people age 12 to 64 who have a least one health condition that puts them at increased risk ...

The US Food and Drug Administration (FDA) has expanded the approved use of Nubeqa (darolutamide) for patients with metastatic castration-sensitive prostate cancer (mCSPC). The drug is now approved for ...

Roche leads the clinical development of Evrysdi as part of a collaboration with the SMA Foundation and PTC Therapeutics.

Humans have spent thousands of years experimenting with weight loss aids. While Ozempic and Wegovy may be generating ...